International Journal of Phonosurgery & Laryngology

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  14 (2024)
Volume  13 (2023)
Volume  12 (2022)
Volume  11 (2021)
Volume  10 (2020)
Volume  9 (2019)
Volume  8 (2018)
Volume  7 (2017)
Volume  6 (2016)
Volume  5 (2015)
Volume  4 (2014)
Volume  3 (2013)
Volume  2 (2012)
Volume  1 (2011)
Related articles

VOLUME 8 , ISSUE 1 ( January-June, 2018 ) > List of Articles

RESEARCH ARTICLE

Multimodality Treatment for the Contact Granuloma of the Vocal Folds

Sheetal B Radia

Keywords : Botulinum toxin type A injection (BTXA), Contact granuloma, Microlaryngeal surgery, Proton pump inhibitor, Voice therapy

Citation Information : Radia SB. Multimodality Treatment for the Contact Granuloma of the Vocal Folds. Int J Phonosurg Laryngol 2018; 8 (1):46-51.

DOI: 10.5005/jp-journals-10023-1158

License: CC BY-NC 3.0

Published Online: 01-12-2018

Copyright Statement:  Copyright © 2018; The Author(s).


Abstract

Introduction: This study aims to show the response of contact granuloma (CG) to Botulinum toxin type A injection (BTXA), proton pump inhibitors (PPI) and voice therapy (VT). Materials and methods: A non-randomized prospective analytical study was done at a tertiary care hospital, in which 70 patients with CG were seen over a 2 years period. Depending on the size of the CG, the patients were divided into three groups and treated as below: Group A: VT + BTXA+ PPI for farewell grade I and II CG Group B: VT + BTXA + PPI + Microlaryngeal surgery (MLS) for Farewell Grade III and IV CG Group C: VT + PPI (a group which did not agree for BTXA). Statistical analysis: Data were analyzed and stored using Microsoft Excel 2010 file and qualitative data was represented in the form of frequency and percentage. Results: Of the 70 patients in our study, we included 30 patients in group A, 19 in group B and 21 included in group C. All Group A patients (100%) resolved; however 1 patient needed a reinjection of BTXA. In group B, 18 patients (94.7%) resolved,1 patient (5.3%) had recurrence. In Group C, 18 patients (85.7%) resolved, and three patients (14.3%) had persistent CG. Conclusion: In our study, patients of farewell grade I and II treated with BTXA, PPI and VT had a 100% resolution rate. Surgery along with BTXA, PPI and VT is an acceptable treatment modality for farewell grade III and IV CG, as our study indicated a 94.7% success rate and 5.3% recurrence rate. The patients who did not receive BTXA had a decreased rate of resolution (85.7%).

PDF Share
  1. Storck C, Brockmann M, Zimmermann E, Nekahm-Heiss D. Laryngel Granuloma Aetiology, Clinical Signs, diagnostic procedure and treatment HNO. 2009 Oct;57(10):1075-1080.
  2. Yilmaz T, Suslu N, Atay G, Ozer S, Gunaydin RO, Bajin MD. Recurrent contact granuloma: experience with excision and botulinum toxin injection. JAMA Otolaryngol Head Neck Surg. 2013 Jun;139(6):579-583.
  3. Ward PH, Zwitman D, Hanson D, Berci G. Contact ulcers and granulomas of larynx a new insights into their etiology as basis for more rational treatment. Otolaryngology and Head and Neck surgery. 1980 May-June;88(3):262-269.
  4. Farewell DG, Belafsy PC, Rees CJ. An Endoscopic grading system for vocal process Granuloma. J Laryngol Otol. 2008 Mar;122(10):1092-1095.
  5. Leonard R, Kendall K. Effects of voice therapy on vocal process granuloma: a phonoscopic approach. Am J Otolar-yngol.2005 Mar-Apr,26(2);101-7.
  6. Jackson C, Jackson CL. Contact ulcer of the larynx. Arch Otolaryngol. 1935;July;22:1-15.
  7. Feder RJ, Mitchee MJ. Hyperfunctional, hyperacid, and Intubational granuloma. Arch otolaryngol. 1984 Sep;110:582-584.
  8. Brodnitz F. Contact ulcer of the larynx. Arch Otolaryngol Head Neck Surg 1961 July;74:70-80.
  9. Havas TE, Priestley J, Lowinger DS. A management strategy for vocal process granuloma. Laryngoscope. 1999 Feb;109(2 pt 1):301-306.
  10. De Lima Pontes PA, De Biase NG, Gadelha EC. Clinical evolution of laryngeal granulomas: treatment and prognosis. Laryngoscope. 1999 Feb;109(2 pt 1):289-294.
  11. Holinger PH, Johnston KC. Contact ulcer of the larynx. Journal of the American Medical Association. 1960 Feb 6;172(6):511- 515.
  12. Benjamin B, Croxson G. Vocal cord granulomas. Annals of Otology, Rhinology & Laryngology. 1985 Nov;94(6):538-541.
  13. McFerran DJ, Abdullah V, Gallimore AP, Pringle MB, Croft CB. Vocal process granulomata. The Journal of Laryngology & Otology. 1994 Mar;108(3):216-220.
  14. De Lima Pontes PA, De Biase NG, Gadelha ME. Clinical evolution of laryngeal granulomas: treatment and prognosis. The Laryngoscope. 1999 Feb;109(2):289-294.
  15. Emami AJ, Morrison M, Rammage L, Bosch D. Treatment of laryngeal contact ulcers and granulomas: a 12-year retrospective analysis. Journal of Voice. 1999 Dec 1;13(4):612-617.
  16. Bloch CS, Gould WJ, Hirano M. Effect of voice therapy on contact granuloma of the vocal fold. Annals of Otology, Rhinology & Laryngology. 1981 Jan;90(1):48-52.
  17. Jaroma M, Pakarinen L, Nuutinen J. Treatment of vocal cord granuloma. Acta oto-laryngologica. 1989 Jan 1;107(3-4):296-299.
  18. Nasri S, Sercarz JA, Mcalpin T, Berke GS. Treatment of vocal fold granuloma using botulinum toxin type A. The Laryngoscope. 1995 Jun;105(6):585-588.
  19. Damrose EJ, Damrose JF. Botulinum toxin as adjunctive therapy in refractory laryngeal granuloma. J Laryngol Otol. 2008 Aug;122(8):824-828.
  20. Lee SW, Hong HJ, Choi SH, Sun DI, Park YH, et al. Comparison of treatment modalities for contact granuloma: a nationwide multicenter study. The Laryngoscope. 2014 May;124(5):1187-1191.
  21. Pham J, Yin S, Morgan M, Stucker F, Nathan CA. Botulinum toxin: helpful adjunct to early resolution of laryngeal granulomas. The Journal of Laryngology & Otology. 2004 Oct;118(10):781-785.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.